Page
Number
|
|||
Part
I.
|
Financial
Information
|
||
Item
1.
|
Financial
Statements (Unaudited)
|
||
Consolidated
Balance Sheets –
September
30, 2007 (unaudited) and December 31, 2006
|
3
|
||
Consolidated
Statements of Operations – Three and nine-months ended September 30, 2007
and 2006 (unaudited)
|
4
|
||
Consolidated
Statements of Cash Flow – Nine-months ended September 30, 2007 and 2006
(unaudited)
|
5
|
||
Notes
to Consolidated Financial Statements (unaudited)
|
6
|
||
|
Item
2.
|
Management’s
Discussion and Analysis of Financial Condition and Results of
Operations
|
10
|
Item
3.
|
Controls
and Procedures
|
16
|
|
Part
II.
|
Other
Information
|
||
Item
1.
|
Legal
Proceedings
|
17
|
|
Item
2.
|
Changes
in Securities and Use of Proceeds
|
17
|
|
Item
6.
|
Exhibits
|
18
|
|
Signatures
|
19
|
||
EX-31.1
|
|||
EX-31.2
|
|||
EX-32.1
|
|||
EX-32.2
|
September
30,
2007
|
December
31,
2006
|
||||||
(Unaudited)
|
|||||||
ASSETS
|
|||||||
Current
Assets:
|
|||||||
Cash
|
$
|
1,168,803
|
$
|
2,136,414
|
|||
Certificate
of deposit, restricted
|
207,298
|
198,266
|
|||||
Accounts
receivable:
|
|||||||
Long-term
care resident receivables, net
|
2,187,632
|
1,949,745
|
|||||
Management,
consulting and development receivables, net
|
252,566
|
254,321
|
|||||
Advances
and receivables from affiliates
|
24,664
|
35,897
|
|||||
Assets
of discontinued operations
|
446
|
4,677
|
|||||
Prepaid
expenses and other
|
501,621
|
337,638
|
|||||
Total
current assets
|
4,343,030
|
4,916,958
|
|||||
Restricted
Cash
|
957,343
|
914,941
|
|||||
Property
and Equipment, Net
|
14,228,260
|
13,750,870
|
|||||
Note
Receivable, Net
|
230,413
|
257,413
|
|||||
License,
Net
|
1,189,306
|
1,189,306
|
|||||
Goodwill
|
2,638,193
|
2,638,193
|
|||||
Assets
of Discontinued Operations, Net of Current Portion
|
-
|
880,430
|
|||||
Other
Assets
|
1,041,615
|
838,283
|
|||||
Total
assets
|
$
|
24,628,160
|
$
|
25,386,394
|
|||
LIABILITIES
AND STOCKHOLDERS’ EQUITY
|
|||||||
Current
Liabilities:
|
|||||||
Current
portion of notes payable and other debt
|
$
|
813,798
|
$
|
744,131
|
|||
Current
portion of note payable to stockholder
|
9,466
|
828,344
|
|||||
Accounts
payable and accrued expenses
|
3,767,172
|
3,804,590
|
|||||
Liabilities
of discontinued operations
|
-
|
22,177
|
|||||
Total
current liabilities
|
4,590,436
|
5,399,242
|
|||||
Notes
Payable and Other Debt, Net of Current Portion
|
12,625,359
|
12,909,162
|
|||||
Note
Payable to Stockholder, Net of Current Portion
|
811,433
|
-
|
|||||
Other
Liabilities
|
338,263
|
262,597
|
|||||
Forward
Purchase Contract
|
900,000
|
900,000
|
|||||
Liabilities
of Discontinued Operations
|
-
|
848,394
|
|||||
Minority
Interest in Equity of Consolidated Entities
|
228,815
|
160,259
|
|||||
Total
liabilities
|
19,494,306
|
20,479,654
|
|||||
Stockholders'
equity:
|
|||||||
Preferred
stock, no par value; 500,000 shares authorized; no
shares issued or outstanding
|
-
|
-
|
|||||
Common
stock and additional paid-in capital, no par value; 14,500,000
shares
authorized; 3,786,129 and 3,778,129 shares issued and
outstanding
|
14,036,155
|
13,857,166
|
|||||
Accumulated
deficit
|
(8,902,301
|
)
|
(8,950,426
|
)
|
|||
Total
stockholders' equity
|
5,133,854
|
4,906,740
|
|||||
Total
liabilities and stockholders' equity
|
$
|
24,628,160
|
$
|
25,386,394
|
Three-Months
Ended
|
Nine-Months
Ended
|
||||||||||||
September
30,
|
September
30,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Revenues:
|
|||||||||||||
Patient
care revenues
|
$
|
5,468,027
|
$
|
5,226,756
|
$
|
16,292,143
|
$
|
15,352,272
|
|||||
Management,
consulting and development fee revenue
|
438,299
|
433,581
|
1,310,908
|
1,271,254
|
|||||||||
Total
revenue
|
5,906,326
|
5,660,337
|
17,603,051
|
16,623,526
|
|||||||||
Expenses:
|
|||||||||||||
Payroll
and related payroll costs
|
3,746,406
|
3,559,660
|
11,088,853
|
10,559,092
|
|||||||||
Other
operating expenses
|
1,855,225
|
1,824,999
|
5,559,608
|
5,336,836
|
|||||||||
Depreciation
and amortization
|
222,843
|
191,407
|
632,126
|
563,951
|
|||||||||
Total
expenses
|
5,824,474
|
5,576,066
|
17,280,587
|
16,459,879
|
|||||||||
Income
from Continuing Operations
|
81,852
|
84,271
|
322,464
|
163,647
|
|||||||||
|
|||||||||||||
Other
Income (Expense):
|
|||||||||||||
Interest
income
|
13,586
|
11,472
|
46,894
|
13,920
|
|||||||||
Interest
expense, others
|
(250,693
|
)
|
(753,797
|
)
|
(767,465
|
)
|
(2,104,304
|
)
|
|||||
Interest
expense, related parties
|
(16,023
|
)
|
(20,771
|
)
|
(35,683
|
)
|
(62,887
|
)
|
|||||
Minority
interest in (earnings) losses of consolidated entities
|
(4,548
|
)
|
23,226
|
(68,556
|
)
|
80,760
|
|||||||
Other
expense
|
(37,014
|
)
|
-
|
(37,014
|
)
|
-
|
|||||||
(294,692
|
)
|
(739,870
|
)
|
(861,824
|
)
|
(2,072,511
|
)
|
||||||
Loss
Before Discontinued Operations
|
(212,840
|
)
|
(655,599
|
)
|
(539,360
|
)
|
(1,908,864
|
)
|
|||||
Discontinued
Operations:
|
|||||||||||||
Income
from discontinued operations
|
608,625
|
953
|
587,485
|
(23,643
|
)
|
||||||||
Net
Income (Loss)
|
$
|
395,785
|
$
|
(654,646
|
)
|
$
|
48,125
|
(1,932,507
|
)
|
||||
Net
Income (Loss) Per Share, Basic and Diluted:
|
|||||||||||||
Continuing
operations
|
$
|
(0.06
|
)
|
$
|
(0.33
|
)
|
$
|
(0.14
|
)
|
$
|
(0.96
|
)
|
|
Discontinued
operations
|
0.16
|
0.00
|
0.16
|
(0.01
|
)
|
||||||||
$
|
0.10
|
$
|
(0.33
|
)
|
$
|
0.02
|
$
|
(0.97
|
)
|
||||
Weighted
Average Common Shares Outstanding,
|
|||||||||||||
Basic
|
3,786,129
|
1,996,150
|
3,786,129
|
1,996,150
|
|||||||||
Diluted
|
3,786,129
|
1,996,150
|
3,786,129
|
1,996,150
|
Nine-Months
Ended September 30,
|
|||||||
2007
|
2006
|
||||||
Cash
flows from operating activities:
|
|||||||
Net
income (loss)
|
$
|
48,125
|
$
|
(1,932,507
|
)
|
||
Add
back: (income) loss from discontinued operations
|
(587,485
|
)
|
23,643
|
||||
Net
income (loss) from continuing operations
|
$
|
(539,360
|
)
|
$
|
(1,908,864
|
)
|
|
Adjustments
to reconcile net loss from continuing operations
|
|||||||
to
net cash provided by (used in) operating activities:
|
|||||||
Depreciation
and amortization
|
632,126
|
502,225
|
|||||
Warrants
issued for services
|
30,705
|
-
|
|||||
Stock
option compensation expense
|
16,142
|
-
|
|||||
Minority
interest
|
68,556
|
(80,141
|
)
|
||||
Loss
on disposal of assets
|
-
|
39,963
|
|||||
Discount
on convertible debentures
|
-
|
1,134,000
|
|||||
Note
receivable forgiveness exchanged for rent
|
27,000
|
-
|
|||||
Changes
in certain assets and liabilities:
|
|||||||
Accounts
receivable
|
(224,897
|
)
|
(93,992
|
)
|
|||
Prepaid
expenses and other
|
(190,396
|
)
|
(184,886
|
)
|
|||
Other
assets
|
(155,834
|
)
|
(787,230
|
)
|
|||
Accounts
payable and accrued expenses
|
(59,595
|
)
|
1,714,603
|
||||
Other
liabilities
|
(153,257
|
)
|
16,628
|
||||
Net
cash provided by (used in) operating activities of continuing
operations
|
(548,810
|
)
|
352,306
|
||||
Net
cash provided by (used in) operating activities of discontinued
operations
|
302,080
|
(23,223
|
)
|
||||
Net
cash provided by (used in) operating activities
|
(246,730
|
)
|
329,083
|
||||
Cash
flow from investing activities:
|
|||||||
Increase
in restricted cash
|
(42,402
|
)
|
(69,706
|
)
|
|||
Proceeds
from sale of assets
|
(56,530
|
)
|
-
|
||||
Purchase
of minority interest
|
(11,382
|
)
|
-
|
||||
Purchase
of property plant and equipment
|
(987,581
|
)
|
(987,263
|
)
|
|||
Net
cash used in investing activities of continuing operations
|
(1,097,895
|
)
|
(1,056,969
|
)
|
|||
Net
cash provided by investing activities of discontinued
operations:
|
|||||||
Proceeds
from sale of assets net of associated costs
|
591,329
|
-
|
|||||
Net
cash used in investing activities
|
(506,566
|
)
|
(1,056,969
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Proceeds
from notes payable
|
54,000
|
552,395
|
|||||
Cash
received upon exercise of warrants
|
20,000
|
-
|
|||||
Proceeds
from note payable to stockholder
|
-
|
835,000
|
|||||
Repayment
of note payable to stockholder
|
(7,446
|
)
|
(125,914
|
)
|
|||
Repayment
on notes payable
|
(268,135
|
)
|
(1,162,463
|
)
|
|||
Net
cash provided by (used in) financing activities of continuing
operations
|
(201,581
|
)
|
99,018
|
||||
Net
cash used in financing activities of discontinued
operations:
|
|||||||
Repayment
on notes payable of discontinued operations
|
(12,734
|
)
|
(14,113
|
)
|
|||
Net
cash provided by (used in) financing activities
|
(214,315
|
)
|
84,905
|
||||
Net
Decrease in Cash
|
(967,611
|
)
|
(642,981
|
)
|
|||
Cash,
Beginning
|
2,136,414
|
1,403,877
|
|||||
Cash,
Ending
|
$
|
1,168,803
|
$
|
760,896
|
|||
Supplemental
Disclosure of Cash Flow Information:
|
|||||||
Cash
paid during the period for interest
|
$
|
803,149
|
$
|
553,884
|
|||
Supplemental
Disclosure of Non-Cash Activities:
|
|||||||
Rent
in exchange of note receivable repayment
|
$
|
27,000
|
$
|
-
|
|||
Payment
of existing mortgage at closing of discontinued operations
|
$
|
609,839
|
$
|
-
|
The
accompanying unaudited consolidated financial statements have been
prepared in accordance with U.S. generally accepted accounting principles
for interim financial information and with the instructions to Form
10-QSB
and Article 10 of Regulation S-X. Accordingly they do not include
all of
the information and footnotes required by generally accepted accounting
principles for complete financial statements. In the opinion of the
management of AdCare Health Systems, Inc., all adjustments considered
for
a fair presentation are included and are of a normal recurring nature.
Operating results for the nine months ended September 30, 2007 are
not
necessarily indicative of the results that may be expected for the
year
ending December 31, 2007.
|
(Amounts
in 000s)
|
|||||||||||||||||||
Manage-
|
|||||||||||||||||||
ment
and
|
Home
|
Discon-
|
|||||||||||||||||
Facility
|
Based
|
Total
|
tinued
|
Cor-
|
|||||||||||||||
Based Care
|
Care
|
Segments
|
operations
|
porate
|
Total
|
||||||||||||||
Three-months
ended September 30, 2007:
|
|||||||||||||||||||
Net
Revenue
|
5,483
|
837
|
6,320
|
-
|
(414
|
)
|
5,906
|
||||||||||||
Net
Income (Loss)
|
(288
|
)
|
75
|
(213
|
)
|
609
|
-
|
396
|
|||||||||||
Capital
Spending
|
418
|
-
|
418
|
-
|
-
|
418
|
|||||||||||||
Three-months
ended September 30, 2006:
|
|||||||||||||||||||
Net
Revenue
|
5,476
|
744
|
6,220
|
-
|
(560
|
)
|
5,660
|
||||||||||||
Net
Income (Loss)
|
(658
|
)
|
2
|
(656
|
)
|
1
|
-
|
(655
|
)
|
||||||||||
Capital
Spending
|
111
|
1
|
112
|
-
|
-
|
112
|
|||||||||||||
Nine-months
ended September 30, 2007:
|
|||||||||||||||||||
Net
Revenue
|
16,345
|
2,497
|
18,842
|
-
|
(1,239
|
)
|
17,603
|
||||||||||||
Net
Income (Loss)
|
(724
|
)
|
185
|
(539
|
)
|
587
|
-
|
48
|
|||||||||||
Total
Assets
|
22,149
|
2,479
|
24,628
|
-
|
-
|
24,628
|
|||||||||||||
Capital
Spending
|
983
|
4
|
987
|
-
|
-
|
987
|
|||||||||||||
Nine-months
ended September 30, 2006:
|
|||||||||||||||||||
Net
Revenue
|
15,858
|
1,983
|
17,841
|
-
|
(1,217
|
)
|
16,624
|
||||||||||||
Net
Income (Loss)
|
(1,833
|
)
|
(76
|
)
|
(1,909
|
)
|
(24
|
)
|
-
|
(1,933
|
)
|
||||||||
Total
Assets
|
21,675
|
2,362
|
24,037
|
893
|
-
|
24,930
|
|||||||||||||
Capital
Spending
|
983
|
4
|
987
|
-
|
-
|
987
|
2007 Grants
|
||||
Dividend
yield
|
0
|
%
|
||
Expected
volatility
|
35.00
|
%
|
||
Risk-free
interest rates
|
4.63
|
%
|
||
Expected
lives
|
5 years
|
Weighted
|
||||||||||
Average
|
Weighted
|
|||||||||
September
30,
|
Exercise
|
Average
|
||||||||
2007
|
Price
|
Fair Value
|
||||||||
Beginning
|
99,400
|
$
|
2.50
|
$
|
.36
|
|||||
Granted
|
199,000
|
1.50
|
.58
|
|||||||
Forfeited
|
(4,200
|
)
|
-
|
-
|
||||||
Exercised
|
-
|
-
|
-
|
|||||||
Ending
|
294,200
|
$
|
1.83
|
$
|
.51
|
|||||
Options
exercisable
|
116,240
|
September
30,
2007 |
September
30,
2006 |
Increase/
(Decrease) |
%
Change |
||||||||||
Patient
care revenue
|
$
|
5,468,027
|
$
|
5,226,756
|
$
|
241,271
|
4.6
|
%
|
|||||
Management,
consulting and development fee revenue
|
438,299
|
433,581
|
4,718
|
1.1
|
%
|
||||||||
$
|
5,906,326
|
$
|
5,660,337
|
$
|
245,989
|
4.3
|
%
|
September
30,
2007 |
September
30,
2006 |
Increase/
(Decrease) |
%
Change |
||||||||||
Payroll
and related payroll costs
|
$
|
3,746,406
|
$
|
3,559,660
|
$
|
186,746
|
5.2
|
%
|
|||||
Other
operating expenses
|
1,855,225
|
1,824,999
|
30,226
|
1.7
|
%
|
||||||||
Depreciation
and amortization
|
222,843
|
191,407
|
31,436
|
16.4
|
%
|
||||||||
$
|
5,824,474
|
$
|
5,576,066
|
$
|
248,408
|
4.5
|
%
|
September
30,
2007 |
September
30,
2006 |
Increase/
(Decrease) |
%
Change |
||||||||||
Patient
care revenue
|
$
|
16,292,143
|
$
|
15,352,272
|
$
|
939,871
|
6.1
|
%
|
|||||
Management,
consulting and development fee revenue
|
1,310,908
|
1,271,254
|
39,654
|
3.1
|
%
|
||||||||
$
|
17,603,051
|
$
|
16,623,526
|
$
|
979,525
|
5.9
|
%
|
September
30,
2007 |
September
30,
2006 |
Increase/
(Decrease) |
%
Change |
||||||||||
Payroll
and related payroll costs
|
$
|
11,088,853
|
$
|
10,559,092
|
$
|
529,761
|
5.0
|
%
|
|||||
Other
operating expenses
|
5,559,608
|
5,336,836
|
222,772
|
4.2
|
%
|
||||||||
Depreciation
and amortization
|
632,126
|
563,951
|
68,175
|
12.1
|
%
|
||||||||
$
|
17,280,587
|
$
|
16,459,879
|
$
|
820,708
|
5.0
|
%
|
September
30, 2007
|
December
31, 2006
|
||||||||||||
Gross
offering proceeds (703,000 units x $9.50 per unit)
|
6,678,500
|
6,678,500
|
|||||||||||
Underwriting
discounts and commissions
|
534,280
|
534,280
|
|||||||||||
Underwriter’s
expenses
|
226,355
|
226,354
|
|||||||||||
Other
expenses (1)
|
175,000
|
175,000
|
|||||||||||
Total
expenses
|
935,635
|
935,634
|
|||||||||||
Net
offering proceeds
|
5,742,865
|
5,742,866
|
|||||||||||
Repayment
of indebtedness
|
2,082,152
|
2,082,152
|
|||||||||||
Legal
and accounting fees related to the offering
|
696,702
|
696,702
|
|||||||||||
Working
capital (2)
|
2,455,861
|
936,146
|
|||||||||||
Cash
held in money market account (2)
|
8,150
|
1,527,866
|
|||||||||||
Cash
held in interest bearing saving account
|
500,000
|
500,000
|
|||||||||||
Net
proceeds unaccounted for
|
-
|
-
|
(1)
|
Other
expenses consist of $75,000 paid to Newbridge Securities Corporation
as a
consulting fee in connection with their Financial Advisory Agreement.
$100,000 represents our purchase of the warrants held by Newbridge
Securities Corporation pursuant to the underwriting
agreement.
|
(2)
|
Cash
used for working capital increased $1,519,715 as a result of payments
for
the continued renovations at Hearth & Care of Greenfield as well as
additional payments for audit expenses and working capital. We plan
to
replace cash used for Hearth & Care of Greenfield upon the successful
completion of refinancing the property. At this time, we have no
commitments or guarantees of refinancing Hearth & Care of
Greenfield.
|
a.
|
The
following Exhibits are attached:
|
Exhibit
Number |
Description
|
|
31.1
|
Certification
of CEO pursuant to Section 302 of the Sarbanes-Oxley
Act
|
|
31.2
|
Certification
of CFO pursuant to Section 302 of the Sarbanes-Oxley
Act
|
|
32.1
|
Certification
of CEO pursuant to Section 906 of the Sarbanes-Oxley
Act
|
|
32.2
|
Certification
of CFO pursuant to Section 906 of the Sarbanes-Oxley
Act
|
b.
|
The
Company filed the following Reports on Form 8-K during the three
months
ended September 30, 2007:
|
Date
|
Description
|
|
August
14, 2007
|
Press
release announcing earnings results for the quarter ending June 30,
2007
|
|
September
12, 2007
|
Termination
of definitive merger agreement with Family Home Health Services and
completion of the disposition of assets held by Hearth & Home of
Marion
|
AdCare
Health Systems, Inc.
|
||
(Registrant)
|
||
Date:
November 14, 2007
|
/s/
Gary L. Wade
|
|
Chief
Executive Officer
|
||
Date:
November 14, 2007
|
/s/
Scott Cunningham
|
|
Chief
Financial Officer
|